Abstract | PURPOSE OF REVIEW: The purpose of this review is to describe the physiopathological and therapeutic aspects of neutrophilic dermatosis, taking into account their most frequent associated conditions. RECENT FINDINGS: SUMMARY:
|
Authors | Diane Maalouf, Maxime Battistella, Jean-David Bouaziz |
Journal | Current opinion in hematology
(Curr Opin Hematol)
Vol. 22
Issue 1
Pg. 23-9
(Jan 2015)
ISSN: 1531-7048 [Electronic] United States |
PMID | 25394310
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Antirheumatic Agents
- Interleukin 1 Receptor Antagonist Protein
- Interleukin-1
- Tumor Necrosis Factor-alpha
|
Topics |
- Animals
- Antirheumatic Agents
(therapeutic use)
- Hematologic Neoplasms
(drug therapy, metabolism, pathology)
- Humans
- Interleukin 1 Receptor Antagonist Protein
(therapeutic use)
- Interleukin-1
(metabolism)
- Multiple Myeloma
(drug therapy, metabolism, pathology)
- Paraproteinemias
(drug therapy, metabolism, pathology)
- Pyoderma Gangrenosum
(drug therapy, etiology, metabolism, pathology)
- Sweet Syndrome
(drug therapy, etiology, metabolism, pathology)
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors, metabolism)
|